{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T16:26:17Z","timestamp":1759335977904},"reference-count":45,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.es","elsevier.es","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Medicina Cl\u00ednica"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/j.medcli.2014.11.017","type":"journal-article","created":{"date-parts":[[2015,2,7]],"date-time":"2015-02-07T19:48:25Z","timestamp":1423338505000},"page":"399-403","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Estatinas y autoinmunidad"],"prefix":"10.1016","volume":"145","author":[{"given":"Marcelo","family":"Alvarado C\u00e1rdenas","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ana","family":"Mar\u00edn S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan","family":"Lima Ruiz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.medcli.2014.11.017_bib0230","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: Prospective meta-analysis of data from 90,056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet."},{"key":"10.1016\/j.medcli.2014.11.017_bib0235","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/S0140-6736(14)60240-3","article-title":"Statins for millions more?","volume":"383","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/j.medcli.2014.11.017_bib0240","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1385\/IR:25:3:271","article-title":"Antiinflammatory and immunomodulatory properties of statins","volume":"25","author":"Shovman","year":"2002","journal-title":"Immunol Res."},{"key":"10.1016\/j.medcli.2014.11.017_bib0245","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s12026-013-8409-8","article-title":"Statins and autoimmunity","volume":"56","author":"Khattri","year":"2013","journal-title":"Immunol Res."},{"key":"10.1016\/j.medcli.2014.11.017_bib0250","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat Med."},{"key":"10.1016\/j.medcli.2014.11.017_bib0255","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1136\/ard.2010.133827","article-title":"Statin therapy in lupus-mediated atherogenesis: Two birds with one stone","volume":"70","author":"Van Leuven","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/j.medcli.2014.11.017_bib0260","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/nri1839","article-title":"Statin therapy and autoinmune disease: From protein prenylation to immunomodulation","volume":"6","author":"Greenwood","year":"2006","journal-title":"Nat Rev Immunol."},{"key":"10.1016\/j.medcli.2014.11.017_bib0265","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1038\/82219","article-title":"Statins as a newly recognized type of immunomodulator","volume":"6","author":"Kwak","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/j.medcli.2014.11.017_bib0450","doi-asserted-by":"crossref","first-page":"6988","DOI":"10.4049\/jimmunol.180.10.6988","article-title":"Simvastatin inhibits IL-17 secretion by targeting multiple IL-17-regulatory cytokines and by inhibiting the expression of IL-17 transcription factor RORC in CD4+ lymphocytes","volume":"180","author":"Zhang","year":"2008","journal-title":"J Immunol."},{"key":"10.1016\/j.medcli.2014.11.017_bib0270","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1007\/s000110050622","article-title":"Peroxisome proliferator-activated receptors (PPARs): Nuclear receptors at the crossroads between lipid metabolism and inflammation","volume":"49","author":"Chinetti","year":"2000","journal-title":"Inflamm Res."},{"key":"10.1016\/j.medcli.2014.11.017_bib0275","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/j.1468-3083.2006.01838.x","article-title":"Lupus erythematous and other autoimmune diseases related to statin therapy: A systematic review","volume":"21","author":"No\u00ebl","year":"2007","journal-title":"J Eur Acad Dermatol Venereol."},{"key":"10.1016\/j.medcli.2014.11.017_bib0280","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/0961203312436861","article-title":"Statin-induced lupus: A case\/non-case study in a nationwide pharmacovigilance database","volume":"21","author":"Moulis","year":"2012","journal-title":"Lupus."},{"key":"10.1016\/j.medcli.2014.11.017_bib0285","doi-asserted-by":"crossref","DOI":"10.1136\/bcr.02.2011.3832","article-title":"Simvastatin-induced dermatomyositis in a 50-year-old man","author":"Zaraa","year":"2011","journal-title":"BMJ Case Rep"},{"key":"10.1016\/j.medcli.2014.11.017_bib0290","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1093\/rheumatology\/33.2.199","article-title":"Simvastatin-associated dermatomyositis","volume":"33","author":"Khattak","year":"1994","journal-title":"Br J Rheumatol."},{"key":"10.1016\/j.medcli.2014.11.017_bib0295","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1002\/mus.20127","article-title":"Dermatomyositis-like syndrome and HMG-CoA reductase inhibitor (statin) intake","volume":"30","author":"Vasconcelos","year":"2004","journal-title":"Muscle Nerve."},{"key":"10.1016\/j.medcli.2014.11.017_bib0300","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1097\/00004836-200609000-00018","article-title":"Autoimmune hepatitis triggered by statins","volume":"40","author":"Alla","year":"2006","journal-title":"J Clin Gastroenterol."},{"key":"10.1016\/j.medcli.2014.11.017_bib0305","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1111\/j.1756-185X.2010.01481.x","article-title":"ANCA-positive vasculitis associated with simvastatin\/ezetimibe: Expanding the spectrum of statin-induced autoimmunity?","volume":"13","author":"Sen","year":"2010","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/j.medcli.2014.11.017_bib0310","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1002\/pds.1603","article-title":"The safety of rosuvastatin in comparison with other statins in over 100,000 statins users in UK primary care","volume":"17","author":"Garc\u00eda-Rodr\u00edguez","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/j.medcli.2014.11.017_bib0315","doi-asserted-by":"crossref","first-page":"858","DOI":"10.7326\/0003-4819-150-12-200906160-00009","article-title":"Narrative review: Statin-related myopathy","volume":"150","author":"Joy","year":"2009","journal-title":"Ann Intern Med."},{"key":"10.1016\/j.medcli.2014.11.017_bib0320","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy--A genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/j.medcli.2014.11.017_bib0325","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.nmd.2006.10.007","article-title":"Progressive myopathy with upregulation of MHC-I associated with statin therapy","volume":"17","author":"Needham","year":"2007","journal-title":"Neuromuscul Disord."},{"key":"10.1016\/j.medcli.2014.11.017_bib0330","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1002\/mus.21486","article-title":"Immune-mediated necrotizing myopathy associated with statins","volume":"41","author":"Grable-Esposito","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/j.medcli.2014.11.017_bib0335","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1002\/art.27572","article-title":"A novel autoantibody recognizing 200-kd and 100-kd proteins is associated with an immune-mediated necrotizing myopathy","volume":"62","author":"Christopher-Stine","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2014.11.017_bib0340","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1002\/art.30156","article-title":"Autoantibodies against 3-hydroxy-3-methylglutaryl-coenzyme A reductase in patients with statin-associated autoimmune myopathy","volume":"63","author":"Mammen","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/j.medcli.2014.11.017_bib0345","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1002\/acr.21671","article-title":"Increased frequency of DRB1*11:01 in anti-hydroxymethylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"64","author":"Mammen","year":"2012","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.medcli.2014.11.017_bib0350","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1002\/acr.20662","article-title":"Rarity of anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase antibodies in statin users, including those with self-limited musculoskeletal side effects","volume":"64","author":"Mammen","year":"2012","journal-title":"Arthritis Care Res (Hoboken)."},{"key":"10.1016\/j.medcli.2014.11.017_bib0355","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1097\/01.bor.0000434673.85515.89","article-title":"The spectrum of statin myopathy","volume":"25","author":"Mohassel","year":"2013","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.medcli.2014.11.017_bib0360","unstructured":"Moreno PJ, Grau JM, Milisenda JC, Selva-O\u2019Callaghan A, Losno RA, Jerez A, et al. Clinical presentation and response to treatment of patients with the necrotizing immune-mediated myopathy associated with statins. 13th International Congress on Neuromuscular Diseases. Nice, France, July 5-10, 2014."},{"key":"10.1016\/j.medcli.2014.11.017_bib0365","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/art.34673","article-title":"Antibody levels correlate with creatine kinase levels and strength in anti-3-hydroxy-3-methylglutaryl-coenzyme A reductase-associated autoimmune myopathy","volume":"64","author":"Werner","year":"2012","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medcli.2014.11.017_bib0370","series-title":"Disease of the liver","first-page":"1001","article-title":"Autoimmune hepatitis","author":"Krawit","year":"2003"},{"key":"10.1016\/j.medcli.2014.11.017_bib0375","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1097\/00042737-200308000-00014","article-title":"Autoimmune hepatitis revealed by atorvastatin","volume":"15","author":"Pelli","year":"2003","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.medcli.2014.11.017_bib0380","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1097\/00042737-200505000-00019","article-title":"Rosuvastatin-associated hepatitis with autoimmune features","volume":"17","author":"Wolters","year":"2005","journal-title":"Eur J Gastroenterol Hepatol."},{"key":"10.1016\/j.medcli.2014.11.017_bib0385","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1055\/s-0034-1375959","article-title":"Drug-induced liver injury with autoimmune features","volume":"34","author":"Lemos","year":"2014","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.medcli.2014.11.017_bib0390","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1055\/s-0029-1240010","article-title":"Drug-induced liver injury associated with statins","volume":"29","author":"Russo","year":"2009","journal-title":"Semin Liver Dis."},{"key":"10.1016\/j.medcli.2014.11.017_bib0395","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1001\/archinte.1991.00400080147030","article-title":"Lovastatin-induced lupus erythematous","volume":"151","author":"Ahmad","year":"1991","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.medcli.2014.11.017_bib0400","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1001\/archinte.1992.00400170157032","article-title":"Lupuslike syndrome associated with simvastatin","volume":"152","author":"Bannwarth","year":"1992","journal-title":"Arch Intern Med."},{"key":"10.1016\/j.medcli.2014.11.017_bib0405","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1097\/00007611-199809000-00016","article-title":"Simvastatin-induced lupus erythematosus","volume":"91","author":"Khosla","year":"1998","journal-title":"South Med J."},{"key":"10.1016\/j.medcli.2014.11.017_bib0410","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1097\/00002281-199801000-00007","article-title":"Drugs associated with vasculitis","volume":"10","author":"Merkel","year":"1998","journal-title":"Curr Opin Rheumatol."},{"key":"10.1016\/j.medcli.2014.11.017_bib0415","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1002\/1529-0131(200002)43:2<405::AID-ANR22>3.0.CO;2-5","article-title":"Drug-associated antineutrophil cytoplasmic antibody-positive vasculitis","volume":"43","author":"Choi","year":"2000","journal-title":"Arthritis Rheum."},{"key":"10.1016\/j.medcli.2014.11.017_bib0420","doi-asserted-by":"crossref","first-page":"338","DOI":"10.3109\/s10165-009-0168-y","article-title":"Hydralazine-induced autoimmune disease: Comparison to idiopathic lupus and ANCA-positive vasculitis","volume":"19","author":"Yokogawa","year":"2009","journal-title":"Mod Rheumatol."},{"issue":"Suppl 2","key":"10.1016\/j.medcli.2014.11.017_bib0425","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1007\/s10067-008-1020-z","article-title":"A case of ANCA-associated systemic vasculitis induced by atorvastatin","volume":"27","author":"Haroon","year":"2008","journal-title":"Clin Rheumatol."},{"key":"10.1016\/j.medcli.2014.11.017_bib0430","doi-asserted-by":"crossref","first-page":"91","DOI":"10.5694\/j.1326-5377.2007.tb00809.x","article-title":"Potential link between HMG-CoA reductase inhibitor (statin) use and interstitial lung disease","volume":"186","author":"Walker","year":"2007","journal-title":"Med J Aust."},{"key":"10.1016\/j.medcli.2014.11.017_bib0435","doi-asserted-by":"crossref","first-page":"57","DOI":"10.2515\/therapie:2006017","article-title":"A case of interstitial lung disease with atorvastatin (Tahor) and a review of the literature about these effects observed under statins","volume":"61","author":"Veyrac","year":"2006","journal-title":"Therapie."},{"key":"10.1016\/j.medcli.2014.11.017_bib0440","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1378\/chest.08-0943","article-title":"Statins and interstitial lung disease: A systematic review of the literature and of food and drug administration adverse event reports","volume":"134","author":"Fern\u00e1ndez","year":"2008","journal-title":"Chest."},{"key":"10.1016\/j.medcli.2014.11.017_bib0445","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/thoraxjnl-2012-201823","article-title":"Statins and the risk of interstitial lung disease: A cohort study","volume":"68","author":"Saad","year":"2013","journal-title":"Thorax."}],"container-title":["Medicina Cl\u00ednica"],"original-title":[],"language":"es","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775314008781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0025775314008781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,7]],"date-time":"2024-06-07T02:28:20Z","timestamp":1717727300000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0025775314008781"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,11]]},"references-count":45,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S0025775314008781"],"URL":"https:\/\/doi.org\/10.1016\/j.medcli.2014.11.017","relation":{},"ISSN":["0025-7753"],"issn-type":[{"value":"0025-7753","type":"print"}],"subject":[],"published":{"date-parts":[[2015,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estatinas y autoinmunidad","name":"articletitle","label":"Article Title"},{"value":"Medicina Cl\u00ednica","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.medcli.2014.11.017","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Espa\u00f1a, S.L.U. All rights reserved.","name":"copyright","label":"Copyright"}]}}